IWA
BNGO icon

Intercontinental Wealth Advisors’s Bionano Genomics BNGO Stock Holding History

Intercontinental Wealth Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36
Closed -$66K – 274
2020
Q4 		$66K Buy
+36
New +$13.5K 0.02% 250

Other funds holding BNGO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Intercontinental Wealth Advisors's BNGO Position: Q1 2021 in Review

Intercontinental Wealth Advisors sold out of Bionano Genomics (BNGO) in Q1 2021, closing a stake of 36 shares — an estimated $66K sold.

Intercontinental Wealth Advisors first reported a position in BNGO in Q4 2020 and held it in 1 quarter. The position peaked at $66K in Q4 2020. 109 funds tracked by Wall St. Rank hold BNGO as of Q1 2021.

  • Intercontinental Wealth Advisors reported no remaining Bionano Genomics position as of Q1 2021 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 36 Bionano Genomics shares in Q1 2021, an estimated $66K.
  • Intercontinental Wealth Advisors first reported a position in Bionano Genomics in Q4 2020 and held it in 1 quarter.
  • Intercontinental Wealth Advisors's Bionano Genomics position peaked at $66K in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2021.

Based on Intercontinental Wealth Advisors's 13F filing for Q1 2021, filed 14 May 2021.